National Jewish Health:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:National Jewish Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9300
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Jewish Health (NJH), formerly National Jewish Medical and Research Center is a healthcare service provider that offers treatment for pulmonary, cardiac, immune and related disorders. The center conducts programs in the therapeutic areas of allergy, asthma, bronchicardiology, bronchiectasis, idiopathic pulmonary fibrosis, clinical immunology, COPD, environmental and occupational health, gastroenterology, rheumatology, sleep, interstitial lung disease, nephrology, oncology, pulmonology and respiratory, among others. It offers academic training, professional education, and patient education for physicians, scientists, healthcare professionals, and patients. The center has operations in New York, California, Washington, D.C., Florida and Illinois. NJH is headquartered in Denver, Colorado, the US.

National Jewish Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Jewish Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National Jewish Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
National Jewish Health, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
National Jewish Health, Saint Joseph’s Hospital and SCL Health Announce to Form Joint Venture 10
National Jewish Health Forms Joint Venture With Icahn School of Medicine at Mount Sinai 11
Licensing Agreements 12
Aeolus Pharma Enters into Licensing Agreement with National Jewish Health 12
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 13
National Jewish Health – Key Competitors 14
National Jewish Health – Key Employees 15
National Jewish Health – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Jan 25, 2018: Jefferson Health and National Jewish Health Announce Jesse Roman, MD, as CEO of the Jane & Leonard Korman Respiratory Institute 19
Government and Public Interest 20
Nov 14, 2017: $8.5M Grant Awarded to Improve Asthma Care with the Navajo Nation 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
National Jewish Health, Pharmaceuticals & Healthcare, Key Facts 2
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Jewish Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Jewish Health, Deals By Therapy Area, 2012 to YTD 2018 8
National Jewish Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
National Jewish Health, Saint Joseph's Hospital and SCL Health Announce to Form Joint Venture 10
National Jewish Health Forms Joint Venture With Icahn School of Medicine at Mount Sinai 11
Aeolus Pharma Enters into Licensing Agreement with National Jewish Health 12
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 13
National Jewish Health, Key Competitors 14
National Jewish Health, Key Employees 15
National Jewish Health, Key Employees (cont..) 17
National Jewish Health, Other Locations 18

List of Figures
National Jewish Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Jewish Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[National Jewish Health:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vascular Biogenics Ltd (VBLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Vascular Biogenics Ltd (VBL) is a clinical biopharmaceutical company that discovers, develops and commercializes treatments for cancer. The company’s product pipeline includes VB-111. VBL’s product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for ca …
  • Trubnaya Metallurgicheskaya Kompaniya:企業の戦略・SWOT・財務情報
    Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report Summary Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Swiss Re Group:企業のM&A・事業提携・投資動向
    Swiss Re Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swiss Re Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • African Development Bank Group:企業の戦略的SWOT分析
    African Development Bank Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • genedrive plc (GDR)-製薬・医療分野:企業M&A・提携分析
    Summary genedrive plc (genedrive), formerly Epistem Holdings plc is a molecular diagnostics company. The company focuses on the development and commercialization of simple to use “point of need” system or point of care diagnostics platform for the diagnosis of infectious diseases and use in patient …
  • KVK-Tech Inc-製薬・医療分野:企業M&A・提携分析
    Summary KVK-Tech Inc (KVK-Tech) is a manufacturer and marketer generic drugs. The company's product portfolio includes benzphetamine HCL, betaxolol, chlorphen-12, cyclobenzaprine HCL, diethylpropion HCL, hydroxyzine HCL, indomethacin extended release, phendimetrazine tartrate, phentermine HCL, prome …
  • Mitsubishi Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • AC Immune SA (ACIU):製薬・医療:M&Aディール及び事業提携情報
    Summary AC Immune SA (AC Immune) is a biopharmaceutical company that develops products for treating neurodegenerative diseases. It discovers, designs and develops innovative proprietary medicines to prevent, diagnose and treat neurodegenerative diseases associated with protein misfolding. The compan …
  • Frutarom Industries Ltd (FRUT):企業の財務・戦略的SWOT分析
    Frutarom Industries Ltd (FRUT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Turk Hava Yollari Anonim Ortakligi:戦略・SWOT・企業財務分析
    Turk Hava Yollari Anonim Ortakligi - Strategy, SWOT and Corporate Finance Report Summary Turk Hava Yollari Anonim Ortakligi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • The British United Provident Association Ltd:企業の戦略的SWOT分析
    The British United Provident Association Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • The Depository Trust & Clearing Corp:企業の戦略的SWOT分析
    The Depository Trust & Clearing Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Bank CIC (Switzerland) Ltd.:企業の戦略・SWOT・財務情報
    Bank CIC (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank CIC (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • African Development Bank Group:企業の戦略的SWOT分析
    African Development Bank Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • ENAMINE Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Enamine Ltd (Enamine) is a provider of screening and drug discovery services. The company’s products include building blocks and intermediates, screening compounds, real database, compound libraries, fragment library, tangible building blocks, materials chemistry and scaffolds. It offers ser …
  • National Bank of Greece SA:企業のM&A・事業提携・投資動向
    National Bank of Greece SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Bank of Greece SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Caretech Holdings Plc (CTH):企業の財務・戦略的SWOT分析
    Summary Caretech Holdings Plc (CareTech) is a children and adult care service provider. The company offers solution for adults and solution for children and young people. its adult care services includes learning disability, mental health, acquired brain injury, eating disorders, sensory impairments …
  • California Water Service Group (CWT):企業の財務・戦略的SWOT分析
    Summary California Water Service Group (California Water Service) is a utility service provider that offers wastewater services and water operation and maintenance services. The utility provides services such as water and wastewater utility services, and operating water and wastewater systems servic …
  • Atara Biotherapeutics Inc (ATRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Atara Biotherapeutics Inc (Atara) is a biopharmaceutical company that develops T-cell based immunotherapies for the treatment of cancers, other autoimmune diseases, and severe viral infections. The company is evaluating its lead candidate tabelecleucel, formerly ATA129, in Phase 3 for the tr …
  • WPX Energy Inc (WPX):企業の財務・戦略的SWOT分析
    WPX Energy Inc (WPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆